Similar articles

Abstract: Objectives: To detect the serum proteomic patterns by using SELDI-TOF-MS (surface enhanced laser desorption/ ionization-time of flight-mass spectrometry) technology and CM10 ProteinChip in colorectal cancer (CRC) patients, and to evaluate the significance of the proteomic patterns in the tumour staging of colorectal cancer. Methods: SELDI-TOF-MS and CM10 ProteinChip were used to detect the serum proteomic patterns of 76 patients with colorectal cancer, among them, 10 Stage I, 19 Stage II, 16 Stage III and 31 Stage IV samples. Different stage models were developed and validated by support vector machines, discriminant analysis and time-sequence analysis. Results: The Model I formed by 6 protein peaks (m/z: 2759.58, 2964.66, 2048.01, 4795.90, 4139.77 and 37761.60) could be used to distinguish local CRC patients (Stage I and Stage II) from regional CRC patients (Stage III) with an accuracy of 86.67% (39/45). The Model II formed by 3 protein peaks (m/z: 6885.30, 2058.32 and 8567.75) could be used to distinguish locoregional CRC patients (Stage I, Stage II and Stage III) from systematic CRC patients (Stage IV) with an accuracy of 75.00% (57/76). The Model III could distinguish Stage I from Stage II with an accuracy of 86.21% (25/29). The Model IV could distinguish Stage I from Stage III with accuracy of 84.62% (22/26). The Model V could distinguish Stage II from Stage III with accuracy of 85.71% (30/35). The Model VI could distinguish Stage II from Stage IV with accuracy of 80.00% (40/50). The Model VII could distinguish Stage III from Stage IV with accuracy of 78.72% (37/47). Different stage groups could be distinguished by the two-dimensional scattered spots figure obviously. Conclusion: This method showed great success in preoperatively determining the colorectal cancer stage of patients.

[1] Alexe, G., Alexe, S., Liotta, L.A., Petricoin, E., Reiss, M., Hammer, P.L., 2004. Ovarian cancer detection by logical analysis of proteomic data. Proteomics, 4(3):766-783.

[2] Chen, Y.D., Zheng, S., Yu, J.K., Hu, X., 2004. Development of serum biomarker model and its application in colorectal cancer diagnosis. J. Tumor. Marker Oncol., 19(3):251-258.

[3] Greenlee, R.T., Murray, T., Bolden, S., Wingo, P.A., 2000. Cancer statistics 2000. CA Cancer J. Clin., 50(1):7-33.

[4] Harris, G.J., Church, J.M., Senagore, A.J., Lavery, I.C., Hull, T.L., Strong, S.A., Fazio, V.W., 2002. Factors affecting local recurrence of colonic adenocarcinoma. Dis. Colon Rectum, 45(8):1029-1034.

[5] Hawk, E.T., Levin, B., 2005. Colorectal cancer prevention. J. Clin. Oncol., 23(2):378-391.

[6] Issaq, H.J., Veenstra, T.D., Conrads, T.P., Felschow, D., 2002. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun., 292(3):587-592.

[7] Kotake, K., Koyama, Y., 1995. Neoadjuvant therapy for colorectal cancer. Gan. to Kagaku Ryoho, 22(13):1886-1892.

[8] Merchant, M., Weinberger, S.R., 2000. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis, 21(6):1164-1177.

[9] Paradis, V., Degos, F., Dargere, D., Pham, N., Belghiti, J., Degott, C., Janeau, J.L., Bezeaud, A., Delforge, D., Cubizolles, M., et al., 2005. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology, 41(1):40-47.

[10] Ries, L.A., Wingo, P.A., Miller, D.S., Howe, H.L., Weir, H.K., Rosenberg, H.M., Vernon, S.W., Cronin, K., Edwards, B.K., 2000. The annual report to the nation on the status of cancer, 1973~1997, with a special section on colorectal cancer. Cancer, 88(10):2398-2424.

[11] Semmes, O.J., Feng, Z., Adam, B.L., Banez, L.L., Bigbee, W.L., Campos, D., Cazares, L.H., Chan, D.W., Grizzle, W.E., Izbicka, E., et al., 2005. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin. Chem., 51(1):102-112.

[12] Weinberger, S.R., Morris, T.S., Pawlak, M., 2000. Recent trends in protein biochip technology. Pharmacogenomics, 1(4):395-416.

[13] Zheng, S., Cai, S.R., 2003. Colorectal cancer epidemiology and prevention study in China. Chinese-German J. Clin. Oncol., 2(2):72-75.

[14] Zhukov, T.A., Johanson, R.A., Cantor, A.B., Clark, R.A., Tockman, M.S., 2003. Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer, 40(3):267-279.